Department of Cardiothoracic, Transplant and Vascular Surgery, Hannover Medical School, Hannover, Germany.
Department of Respiratory Medicine, Hannover Medical School, Hannover, Germany.
Eur J Cardiothorac Surg. 2017 Jul 1;52(1):163-170. doi: 10.1093/ejcts/ezx047.
In severe pulmonary hypertension, diastolic dysfunction of the left ventricle causes significant morbidity and mortality after lung transplantation, which may be successfully reversed using a protocol based on perioperative veno-arterial extracorporeal membrane oxygenation (ECMO) and early extubation. Here, we present echocardiographic data and mid-term outcomes.
The records of lung transplanted patients at our institution between May 2010 and January 2016 were retrospectively reviewed. Echocardiography data were collected preoperatively, at discharge, 3 and 12 months after transplantation.
During the study period, 717 patients underwent lung transplantation at our institution, 38 (5%) patients being transplanted for severe pulmonary hypertension. All patients underwent bilateral lung transplantation on veno-arterial ECMO cannulated in the groin, through a sternum sparing thoracotomy in 36 (95%) patients. Extubation was performed early, after a median of 2 days, and awake ECMO was extended for at least 5 days after transplantation. The survival at 3 months, 1 year and 5 years was not different in comparison to patients transplanted for other underlying diseases ( P = 0.45). At 1 year, tricuspid valve regurgitation had disappeared in all patients. The median of the left ventricular end-diastolic dimension improved from 40 (32-44) mm preoperatively to 45 (44-47) mm at 12 months after lung transplantation ( P < 0.05). The median of the proximal right ventricular outflow diameter decreased to 25 (23-27) mm after 12 months, compared to 48 (43-51) mm preoperatively ( P < 0.05).
The routine application of a prophylactic postoperative veno-arterial ECMO protocol in patients with severe pulmonary hypertension undergoing lung transplantation decreases postoperative mortality and favours achievement of normal cardiac function after 1 year.
在严重肺动脉高压中,左心室舒张功能障碍会导致肺移植后出现显著的发病率和死亡率,而使用基于围手术期静脉-动脉体外膜肺氧合(ECMO)和早期拔管的方案可能会成功逆转这种情况。在这里,我们提供了超声心动图数据和中期结果。
回顾性分析了 2010 年 5 月至 2016 年 1 月期间我院接受肺移植的患者的病历。收集了患者术前、出院时、移植后 3 个月和 12 个月的超声心动图数据。
在研究期间,我院共进行了 717 例肺移植,其中 38 例(5%)为严重肺动脉高压患者。所有患者均在腹股沟处插管接受静脉-动脉 ECMO,通过胸骨旁开胸术进行双侧肺移植,其中 36 例(95%)患者接受了该手术。患者在术后 2 天内即被早期拔管,清醒 ECMO 延长至移植后至少 5 天。与因其他基础疾病而接受移植的患者相比,这些患者在 3 个月、1 年和 5 年时的存活率无差异(P=0.45)。在 1 年时,所有患者的三尖瓣反流均已消失。左心室舒张末期内径中位数从术前的 40(32-44)mm 改善至术后 12 个月时的 45(44-47)mm(P<0.05)。术后 12 个月时,右心室流出道近端直径中位数下降至 25(23-27)mm,而术前为 48(43-51)mm(P<0.05)。
在严重肺动脉高压患者接受肺移植时常规应用预防性术后静脉-动脉 ECMO 方案可降低术后死亡率,并有利于在 1 年后实现正常的心功能。